Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets
Authors:
- Steven R. LentzSLSteven R. Lentz
- Timothy L. RatliffTRTimothy L. Ratliff
- 1 November 2004
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 32 (11) , 1073-1081
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cellsBlood, 2004
- Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute anginaHeart, 2004
- CD40-CD40L and Platelet FunctionCirculation Research, 2003
- Endothelium Down-Regulates Fas, TNF, and TRAIL-Induced Neutrophil ApoptosisSurgical Infections, 2002
- Inflammatory role of platelets in acute coronary syndromesHeart, 2001
- Antiviral response by natural killer cells throughTRAIL gene induction by IFN-α/βEuropean Journal of Immunology, 2001
- Isolation and Molecular Characterization of the 5′-Upstream Region of the Human TRAIL GeneBiochemical and Biophysical Research Communications, 2000
- Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive diseaseBlood Coagulation & Fibrinolysis, 2000
- Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARα fusion proteinLeukemia, 1998
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995